Filtros de búsqueda

Lista de obras de

A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt

scientific article published on 30 January 2020

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2017

Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II study

GES: A validated simple score to predict risk of HCC in patients with HCV-GT4 associated advanced liver fibrosis after oral antivirals

artículo científico publicado en 2020

Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study

artículo científico publicado en 2020

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.

artículo científico publicado en 2016

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-center cohort of European cirrhotics

artículo científico publicado en 2020

Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience

artículo científico publicado en 2018

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda